Atlas Trials

Endostatin Combined With Chemotherapy for Adjuvant Treatment of Esophageal Cancer

Clinical trial NCT03649945 · UNKNOWN

Trial details

NCT number
NCT03649945
Sponsor
First Affiliated Hospital of Guangxi Medical University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Esophageal Cancer
Start date
2018-11-01
Primary completion
2020-11-01
Enrollment
186

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.